Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway
Author(s) -
Ting He,
Xiaozhi Bai,
Longlong Yang,
Lei Fan,
Yan Li,
Linlin Su,
Jianxin Gao,
Shichao Han,
Dahai Hu
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430385
Subject(s) - mapk/erk pathway , hypertrophic scar , scars , chemistry , p38 mitogen activated protein kinases , in vivo , ex vivo , kinase , microbiology and biotechnology , phosphorylation , in vitro , pathology , biology , medicine , biochemistry
Our previous study confirmed that Loureirin B (LB) can inhibit hypertrophic scar formation. However, the mechanism of LB-mediated inhibition of scar formation is still unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom